Pay in 4 interest-free payments of $7.18 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
The (2S,3S) configuration specified in the IUPAC name indicates controlled stereochemical orientation
Primary research applications include Alzheimer's disease, vascular dementia, age-related cognitive decline, and neurological recovery after brain injury
on a U-100 syringe Total Doses per Vial
Established therapies should generally be considered first-line treatments unless contraindicated
US$ 29.95
US$ 25.08
US$ 29.34
US$ 27.55
US$ 28.16
